Author

F. Uckun

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:rat· 1

Frequent Co-Authors

K. Sahin· 3 shared c. orhan· 2 shared I. Ozercan· 2 shared M. Gitterle· 2 shared M. Volk· 2 shared E. Sahin· 1 shared J. Powell· 1 shared M. Tuzcu· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

K. Sahin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Non-clinical safety profile and pharmacodynamics of two formulations of the anti-sepsis drug candidate Rejuveinix

F. Uckun, c. orhan, J. Powell, E. Sahin, I. Ozercan, M. Volk, K. Sahin

This study shows two Rejuveinix formulations have a favorable safety profile in rats and similarly increase antioxidant levels in tissues, indicating bioequivalence.

bioRxiv · Jan 3, 2021Pharmacology & Toxicology

Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders

F. Uckun, M. Tuzcu, M. Gitterle, M. Volk, K. Sahin

Rejuveinix improves survival in sepsis model mice by reducing brain oxidative stress, suggesting potential for neuroprotective use in sepsis and COVID-19.

bioRxiv · Jan 3, 2021 · PreprintPharmacology & Toxicology

Rejuveinix Reverses Severe Inflammatory Lung Damage in a Mouse Model of Fatal Sepsis

F. Uckun, I. Ozercan, C. Orhan, M. Gitterle, K. Sahin

This study shows that Rejuveinix reduces severe inflammatory lung damage and improves survival in a mouse model of sepsis at a low dose.

bioRxiv · Dec 31, 2020 · PreprintPharmacology & Toxicology